Gainers:
Citigroup Inc. (C) is rising over 2 percent to $27.20. The company's second quarter profit declined from the previous year period, although earnings per share were above Wall Street view. Total revenues for the quarter fell 10 percent and were below the consensus estimate.
Par Pharmaceutical Companies Inc. (PRX) is rising over 36 percent to $49.90. The company has agreed to be acquired by an affiliate of TPG in a transaction with an equity value of $1.9 billion or $50.00 per share.
Zogenix, Inc. (ZGNX) is up more than 8 percent to $2.39. The company announced that the FDA has accepted for review the New Drug Application for Zohydro ER (hydrocodone bitartrate extended-release capsules).
Human Genome Sciences (HGSI) is gaining over 3 percent to $14.03. There were reports that GlaxoSmithKline plc (GSK,GSK.L) is in friendly talks to acquire the company for more than $2.6 billion.
Trading halt:
Trading in shares of Woodward, Inc. (WWD) was halted. The company announced third quarter preliminary results, which were sharply below Wall Street view. The company noted that its Aerospace segment sales and earnings came in below expectations for the quarter. The company also lowered its fiscal year forecast, in light of macroeconomic uncertainty and the issues identified in the third quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.